Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
Giulia Fulci(Massachusetts General Hospital), E. Antonio Chiocca(Center for Cancer Research), Michael A. Caligiuri(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Davide Gianni(AstraZeneca (Germany)), Sarah Rhee(Harvard University Press), Jianhua Yu(University of California, Irvine), Ralph Weissleder(Massachusetts General Hospital), Laura M. Breymann(Harvard University Press), David N. Louis(Brigham and Women's Hospital), Kazuhiko Kurozomi(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Balveen Kaur(Augusta University)
Cited by 360
Related Papers
The 2007 WHO Classification of Tumours of the Central Nervous System
|Acta Neuropathologica|2007|4.6k
A clearer vision for in vivo imaging
|Nature Biotechnology|2001|3.8k
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k
Imaging in the era of molecular oncology
|Nature|2008|2.3k
Epigenetic memory in induced pluripotent stem cells
|Nature|2010|2.3k